Improvement for high fat diet-induced hepatic injuries and oxidative stress by flavonoid-enriched extract from Nelumbo nucifera leaf

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 13, 2009, Pages 5925-5932

  Lin, Ming Cheng ^a,b   Kao, Shao Hsuan ^b   Chung, Pei Jun ^b   Chan, Kuei Chuan ^a,b   Yang, Mon Yuan ^b   Wang, Chau Jong ^b,c  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Fatty liver; Hypercholesterolemia; Hyperlipidemia; Nelumbo nucifera

Indexed keywords

FLAVONOID; LIPID A; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; FAT INTAKE; HAMSTER; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID PEROXIDATION; LIVER; LIVER DISEASE; NELUMBO; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT LEAF; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; DIETARY FATS; FLAVONOIDS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; LIPID A; LIPID PEROXIDATION; LIVER; LIVER DISEASES; MESOCRICETUS; NELUMBO; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES;

CRICETINAE; NELUMBO; NELUMBO NUCIFERA;

EID: 67649846012     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf901058a     Document Type: Article

References (44)

1. Liu, C. P.; Tsai, W. J.; Lin, Y, L.; Liao, J. F.; Chen, C. F.; Kuo, Y. C. The extracts from Nelumbo nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. Life Sci. 2004, 75, 699-716.
2. Sohn, D. H.; Kim, Y. C.; Oh, S. H.; Park, E. J.; Li, X.; Lee, B. H. Hepatoprotective and free radical scavenging effects of Nelumbo nucifera. Phytomedicine 2003, 10, 165-169.
3. Mukherjee, P. K.; Saha, K.; Pal, M.; Saha, B, P. Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats. J. Ethnopharmgcol. 1997, 58, 207-213.
4. Mukherjee, P. K.; Saha, K.; Das, J.; Pal, M.; Saha, B, P. Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Panta Med 1997, 63, 367-369.
5. Mukherjee, P. K.; Das, J.; Saha, K.; Giri, S. N.; Pal, M.; Saha, B. P. Antipyretic activity of Nelumbo nucifera rhizome extract. Indian J. Exp. Biol. 1996, 34, 275-276.
6. Ono, Y.; Hattori, E.; Fukaya, Y.; Imai, S.; Ohizumi, Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J. Ethnopharmacol. 2006, 106, 238-244.
7. Ohkoshi, E.; Miyazaki, H.; Shindo, K.; Watanabe, H.; Yoshida, A.; Yajima, H. Constituents from the leaves of Nelumbo nucifera stimulate lipolysis in the white adipose tissue of mice. Planta Med. 2007, 73, 1255-1259.
8. Damjanovic, M.; Barton, M. Fat intake and cardiovascular res ponse. Curr. Hyperlens. Rep. 2008, 10, 25-31.
9. Cerf, M. E. High fat diet modulation of glucose sensing in the beta-cell. Med. Sci. Monit. 2007, 13, RA12-RA17.
10. Glass, C. K.; Witztum, J. L. Atherosclerosis the road ahead. Cell 2001, 104, 503-516.
11. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-924.
12. Steinberg, D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 1995, 369, 39-48.
13. Rusinol, A. E.; Yang, L.; Thewke, D.; Panini, S. R.; Kramer, M. F.; Sinensky, M. S. Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J. Biol. Chem. 2000, 275, 7296-7303.
14. Lovejoy, J.; DiGirolamo, M. Habitual dietary intake and insulin sensitivity in lean and obese adults. Am. J. Clin. Nutr. 1992, 55, 1174-1179.
15. Marshall, J. A.; Hoag, S.; Shetterly, S.; Hamman, R. F. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994, 17, 50-56.
16. Vessby, B.; Aro, A.; Skarfors, E.; Berglund, L.; Salminen, I.; Lithell, H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994, 43, 1353-1357.
17. Laing, S. P.; Swerdlow, A. J.; Slater, S. D.; Burden, A. C.; Morris, A.; Waugh, N. R.; Gatling, W.; Bingley, P. J.; Patterson, C. C. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 46, 760-765.
18. Cong, W. N.; Tao, R. Y.; Tian, J. Y.; Liu, G. T.; Ye, F. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci. 2008, 82, 983-990.
19. Caldwell, S. H.; Oelsner, D. H.; Iezzoni, J. C.; Hespenheide, E. E.; Battle, E. H.; Driscoll, C. J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29, 664-669.
20. Bugianesi, E.; Leone, N.; Vanni, E.; Marchesini, G.; Brunello, F.; Carucci, P.; Musso, A.; De Paolis, P.; Capussotti, L.; Salizzoni, M.; Rizzetto, M. Expanding the natural history' of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123, 134-140.
21. Ratziu, V.; Bonyhay, L.; Di Martino, V.; Charlotte, F.; Cavallaro, L.; Sayegh-Tainturier, M. H.; Giral, P.; Grimaldi, A.; Opolon, P.; Poynard, T. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35, 1485-1493.
22. Lee HJC, C. C.; Chou, F. P.; Wu, C. H.; Lai", F. S.; Yang, M. Y.; Wang, C. J. Water extracts from Nelumbo nucifera leaf reduced plasma lipids and atherosclerosis in cholesterol fed rabbits. J. Food Biochem. 2008, in press.
23. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
24. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
25. Bergmeyer, H. U.; Bowers, G. N. Jr.; horder, M.; Moss, D. W. Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase. Clin. Chim. Acta 1976, 70, F19-29.
26. Mazzachi, B. C.; Peake, M. J.; Ehrhardt, V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Chem. Lab. (Heidelberg, Ger.) 2000, 46, 53-55.
27. Tietz, N. W.; Thompson, J. Possible concentration-dependent suppression of immune response by verapamil. Arch. Fam. Med. 1995, 4, 368-369.
28. Lin, C. C.; Shieh, D. E.; Yen, M. H. Hepatoprotective effect of the fractions of Ban-zhilian on experimental liver injuries in rats. J. Ethnopharmacol. 1997, 56, 193-200.
29. Hill, J. O.; Wyatt, H. R.; Reed, G. W.; Peters, J. C. Obesity and the environment: where do we go from here?. Science 2003, 299, 853-855.
30. Klein, S.; Burke, L. E.; Bray, G. A.; Blair, S.; Allison, D. B.; Pi-Sunyer, X.; Hong, Y.; Eckel, R. H. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004, 110, 2952-2967.
31. Larsson, B.; Bjorntorp, P.; Tibblin, G. The health consequences of moderate obesity. Int. J. Obes. 1981, 5, 97-116.
32. Wen, Z.; Dumas, T. E.; Schrieber, S. J.; Hawke, R. L.; Fried, M. W.; Smith, P. C. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab. Dispos. 2008, 36, 65-72.
33. Schümann, J.; Prockl, J.; Kiemer, A. K.; Vollmar, A. M.; Bang, R.; Tiegs, G. Silibinin protects mice from T cell-dependent liver injury. J. Hepatol. 2003, 39, 333-340.
34. Katiyar, S. K.; Roy, A. M.; Baliga, M. S. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol. Cancer Ther. 2005, 4, 207-216.
35. Roy, S.; Kaur, M.; Agarwal, C.; Tecklenburg, M.; Sclafani, R. A.; Agarwal, R. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther. 2007, 6, 2696-2707.
36. Wallace, S.; Vaughn, K.; Stewart, B. W.; Viswanathan, T.; Clausen, E.; Nagarajan, S.; Carrier, D. J. Milk thistle extracts inhibit the oxidation of low-density lipoprotein (LDL) and subsequent scavenger receptor-dependent monocyte adhesion. J. Agric. Food Chem. 2008, 56, 3966-3972.
37. El-Shitany, N. A.; El-Haggar, S.; El-Desoky, K. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem. Toxicol. 2008, 46, 2422-2428.
38. Jerwood, S.; Cohen, J. Unexpected antimicrobial effect of statins. J. Antimicrob. Chemother. 2008, 61, 362-364.
39. Alvarez de Sotomayor, M.; Vega, S.; Mingorance, C.; Marhuenda, E.; Herrera, M. D. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats. Pharmacology 2008, 82, 89-96.
40. Faremi, T. Y.; Sum, S. M.; Fafunso, M. A.; Obioha, U. E. Hepatoprotective potentials of Phyllanthusamarus against ethanol-induced oxidative stress in rats. Food Chem. Toxicol. 2008.
41. Fakurazi, S.; Hairuszah, I.; Nanthini, U. Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem. Toxicol. 2008.
42. Jain, A.; Soni, M.; Deb, L.; Rout, S. P.; Gupta, V. B.; Krishna, K. L. Antioxidant and hepatoprotective activity of ethanolic and aqueous extracts of Momordicadioica Roxb. leaves. J. Ethnopharmacol. 2008, 115, 61-66.
43. Yoo, Y. M.; Nam, J. H.; Kim, M. Y.; Choi, J.; Park, H. I Pectolinarin and pectolinarigenin of Cirsium setidens prevent the hepatic injury in rats caused by D-galactosamine via an antioxidant mechanism. Biol. Pharm. Bull. 2008, 31, 760-764.
44. Jung, H. A.; Kim, J. E.; Chung, H. Y.; Choi, J. S. Antioxidant principles of Nelumbo nucifera stamens. Arch. Pharm. Res. 2003, 26, 279-285.